Is VCXA or JNJ a better dividend investment in 2026?

VCXA currently yields 21.86% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: VCXA offers higher current income.

What is the dividend yield difference between VCXA and JNJ?

VCXA has a forward dividend yield of 21.86% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 18.50 percentage points.

Home › Compare › VCXA vs JNJ

VCXA vs JNJ: Dividend Comparison 2026

VCXA yields 21.86% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 VCXA wins by $61.8K in total portfolio value

INVESTMENT

TIME HORIZON10 years

VCXA

● Live price

21.86%

Share price

$9.15

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$81.8K

Annual income

$8,178.40

Full VCXA calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — VCXA vs JNJ

📍 VCXA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	VCXA	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, VCXA + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

VCXA pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VCXA

Annual income on $10K today (after 15% tax)

$1,857.92/yr

After 10yr DRIP, annual income (after tax)

$6,951.64/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, VCXA beats the other by $6,248.03/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VCXA + JNJ for your $10,000?

VCXA: 50%JNJ: 50%

100% JNJ50/50100% VCXA

Portfolio after 10yr

$50.9K

Annual income

$4,503.09/yr

Blended yield

8.85%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

VCXA

No analyst data

Altman Z

0.2

Piotroski

2/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VCXA buys

JNJ buys

No recent congressional trades found for VCXA or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricVCXAJNJ

Forward yield	21.86% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$81.8K ✓	$20.0K
Annual income after 10y	$8,178.40 ✓	$827.78
Total dividends collected	$48.6K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: VCXA vs JNJ ($10,000, DRIP)

Year	VCXA Portfolio	VCXA Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$12,886	$2,185.79	$10,676	$355.77	+$2.2K → VCXA
2	$16,420	$2,632.31	$11,407	$389.39	+$5.0K → VCXA
3	$20,704	$3,134.85	$12,198	$426.53	+$8.5K → VCXA
4	$25,848	$3,694.19	$13,056	$467.62	+$12.8K → VCXA
5	$31,967	$4,310.21	$13,987	$513.12	+$18.0K → VCXA
6	$39,187	$4,981.93	$14,998	$563.56	+$24.2K → VCXA
7	$47,638	$5,707.54	$16,098	$619.52	+$31.5K → VCXA
8	$57,457	$6,484.45	$17,295	$681.69	+$40.2K → VCXA
9	$68,788	$7,309.37	$18,599	$750.82	+$50.2K → VCXA
10	$81,782	$8,178.40	$20,022	$827.78	+$61.8K → VCXA

VCXA vs JNJ: Complete Analysis 2026

VCXA — Stock

10X Capital Venture Acquisition Corp. II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company intends to focus on identifying technology and tech-enabled businesses in the consumer internet, ecommerce, software, healthcare, transportation/mobility, and financial services industries, as well as other industries that are being disrupted by advances in technology and on technology paradigms, including artificial intelligence automation, data science, ecommerce, and software-as-a-service. 10X Capital Venture Acquisition Corp. II was incorporated in 2021 and is based in New York, New York.

Full VCXA Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this VCXA vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VCXA vs SCHD VCXA vs JEPI VCXA vs O VCXA vs KO VCXA vs MAIN VCXA vs ABBV VCXA vs MRK VCXA vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.